(1R,2R,3S,5R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid

(1R,2R,3S,5R)-2-acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid

NCMJSVDTRDLWJE-GSQQXRCOSA-N CHEBI:181917 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: NCMJSVDTRDLWJE-GSQQXRCOSA-N
InChI Key: NCMJSVDTRDLWJE-GSQQXRCOSA-N
IUPAC name: (1R,2R,3S,5R)-2-acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid
Preferred name: (1R,2R,3S,5R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid
INN name: —
Synonym: —
ChEBI: CHEBI:181917

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide

Observed in differential profiles

Control_vs_OXPA_Treatment